title: [What should Japanese child neurologists do in order to solve the issues of off-label prescription?--Focusing on the use of anti-psychotics in developmental disorders and the acquirement of public approval on the use of steroids in Duchenne muscular dystrophy].
authors.forename: Makiko
authors.initials: M
authors.lastname: Osawa
authors.forename: Masaharu
authors.initials: M
authors.lastname: Hayashi
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D002658:Developmental Disabilities / Q000188:drug therapy*; D006801:Humans; D007564:Japan; D020388:Muscular Dystrophy, Duchenne / Q000188:drug therapy*; D009462:Neurology; D056687:Off-Label Use; D010372:Pediatrics; D010819:Physician's Role; D011239:Prednisolone / Q000627:therapeutic use*
chemical_list: D014150:Antipsychotic Agents; D011239:Prednisolone